The defense contractor Renk posted historic financial results for its last fiscal year, yet its stock is facing significant selling pressure. Investors appear focused on future guidance rather than past achievements, raising questions about what it now takes to satisfy the market.
Strategic US Push and Insider Activity
Beyond the annual figures, Renk is actively executing its growth strategy. Its US subsidiary, Renk America, recently secured maintenance and spare parts contracts valued at $50 million. To solidify its position in this key market, the company has committed to a $150 million investment program at its Michigan site, to be completed by 2030.
Recent transactions by company executives have also drawn attention. CFO Anja Mänz-Siebje initially reported a purchase of company shares, an action typically viewed as a bullish signal. However, a sale by the same executive was disclosed just one day later, sending a more ambiguous message to the market.
Record Revenue and Profitability
Operationally, the propulsion specialist delivered an outstanding performance. Driven by sustained global demand in the defense sector, revenue advanced by nearly one-fifth to €1.37 billion. The vehicle mobility solutions division was a particular standout, expanding by almost 25% and acting as a primary growth engine.
Should investors sell immediately? Or is it worth buying Renk?
Profitability saw a marked improvement as well. Adjusted EBIT (earnings before interest and taxes) rose by approximately 22% to €230 million. Shareholders are set to benefit directly from this success, with the board proposing a dividend of €0.58 per share—a 38% increase year-over-year. Furthermore, the company’s order book provides substantial visibility, having reached an all-time high of €6.68 billion at the turn of the year.
Guidance Disappointment Triggers Sell-Off
The market’s negative reaction stems from the company’s outlook. For the current fiscal year, management forecasts revenue exceeding €1.5 billion and an EBIT ranging between €255 million and €285 million. The midpoint of this EBIT guidance falls short of analyst consensus estimates by about 2%. Company leadership attributed this to orders worth roughly €200 million being rescheduled from the previous year into the first half of 2026.
This modest forecast miss was enough to spark a downturn. The stock recently declined by 2.53% to €54.25, bringing its total loss over the past week to more than 8%. From a technical perspective, the chart has weakened considerably, with the share price now trading notably below its key 50- and 200-day moving averages.
The company’s fundamental position remains solid due to its enormous order backlog, even though short-term expectations have been tempered. Whether the delayed orders will quickly translate into tangible results will become clearer with the next quarterly report on May 6. Until then, the trajectory of operational margins is likely to be the decisive factor for any potential share price recovery.
Ad
Renk Stock: Buy or Sell?! New Renk Analysis from March 12 delivers the answer:
The latest Renk figures speak for themselves: Urgent action needed for Renk investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 12.
Renk: Buy or sell? Read more here...
